Live Cell-Based Assays - We are now expanding our test portfolio by offering Live Cell-Based Assays (CBA) in serum for antibodies against AQP4 and MOG hubs.ly/Q02ZvX-D0

Register to receive your free poster showing the complex hub-like network of the complement system pathways. hubs.ly/Q02Z1sL80

Excited to share insights from scientists at Svar Life Science on the Functional Assessment of #Properdin and modulation of the #AlternativePathway. Learn about innovative approaches shaping the future of #complement therapeutics! hubs.ly/Q02CcRKC0

Learn more about the relevance of antibody-induced Complement‐Dependent Cytotoxicity (CDC) and how to measure the potency of induction or inhibition using advanced functional bioassays. hubs.ly/Q02FlnsZ0

Discover how immune responses affect the immunogenicity, safety, and efficacy of AAV-mediated gene therapy from top experts! 🌟 #GeneTherapy #Webinar #NaturePortfolio #AAVGeneTherapy #Immunogenicity #LifeScience hubs.ly/Q02Z1sZj0

Together with SelectScience, we present a must-read eBook for professionals in the pharmaceutical industry. 📚 Get your free copy and transform your approach to complement therapeutics! #ComplementSystem #ComplementTherapeutics #eBook

Exhibition of the week: Complement-Based Drug Development Summit! Discover Svar's #complement solutions! Explore how we support breakthroughs in ophthalmology, neurology, oncology & more. Meet our experts to accelerate your work in this evolving field.

Regulatory bodies worldwide increasingly recognize the importance of #complement measurement in ensuring the safety and efficacy of #medicaldevices. The Wieslab functional assays enable reproducible and robust assessment of individual pathways. Learn more! hubs.ly/Q02DSlZQ0

🎄 Season's Greetings from all of us! 🎄 Thank you to our customers, partners, and team for an amazing year. Wishing you all joy, peace, and prosperity this holiday season. Let's achieve new heights together in 2025! Happy Holidays! ✨ #HappyHolidays #ThankYou #NewYear2025

Facing issues with neutralizing antibodies in your AAV therapy research? Our iLite® technology is designed to assess NAbs against your specific #AAV vector, offering reliable and consistent results across multiple #serotypes. hubs.ly/Q02DSb270 #Immunogenicity

Are you an experienced Regulatory Affairs Specialist looking for a new challenge? We're hiring! Apply today! hubs.ly/Q031nFpF0 #RegulatoryAffairs #JobOpening #AnswersinLifeScience #CareerOpportunity #JoinUs

Streamline your antibody characterization with the iLite® #CDC #bioassays. With this assay run your experiments immediately without the hassle of cell thawing, counting, or passaging. Improve your efficiency and accelerate data generation. Learn more: hubs.ly/Q02DSqyX0

Our iLite® CDC assay offers a truly reflective CDC cell lysis measurement, developed by our expert scientists to advance therapeutic antibody development. Discover more about its innovative engineering in our editorial article. hubs.ly/Q02DRPnC0 #bispecificantibodies

Want to expand your knowledge on the role of the complement system in infectious disease? Take a deep dive into the #complementsystem and how a better understanding of it can help improve diagnosis and therapy for #infectiousdiseases. hubs.ly/Q02KydV-0

Discover the potential of #Properdin as a crucial regulator in the complement system’s amplification loop. Our case study delves into innovative methods for assessing Properdin function and its implications for #complement therapeutic development. hubs.ly/Q02CcWc70

We're proud to announce that Wieslab Diagnostic Services has successfully renewed its ISO 15189:2022 certification following SWEDAC's inspection this fall! hubs.ly/Q033Jb_t0

Immunogenicity in #AAV therapy can be a significant barrier. iLite® technology provides a robust and reliable solution to assess Neutralizing antibodies (#NAbs) against your unique AAV vector. With proven consistency across different #serotypes. hubs.ly/Q02DS89x0

Excited to share insights from scientists at Svar Life Science on the Assessment of antibody-mediated CDC induction or activation. Learn about innovative approaches shaping the future of therapeutic antibodies! hubs.ly/Q02DR-z90 #bispecificantibodies #bioassay

The #Complement Amplification Loop holds immense potential for therapeutic targeting. Our latest case study explores the functional assessment of #Properdin and #alternativepathway modulation, offering valuable perspectives from Svar complement experts. hubs.ly/Q02CcVRV0

We're proactively aligning with new IVDR standards to keep your trust intact. Count on our innovative team to deliver quality and compliance ahead of the curve. Together, we navigate the future of life science. #IVDR #QualityMatters #IVDR #TrustedPartner #answersinlifescience